A pan-cancer study of PD-1 and CTLA-4 as therapeutic targets

BACKGROUND: Immunotherapy is a new and powerful weapon against tumors, represented by inhibitors of programmed death-1 (PD-1) and cytotoxic T lymphocyte-associated protein-4 (CTLA-4). This study aimed to determine the similarities and differences between PD-1 and CTLA-4 in 33 cancers in The Cancer G...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Zongqiang, Ang, Xiaojie, Xu, Zekun, Li, Shiqing, Zhang, Jianglei, Pei, Changsong, Zhou, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797719/
https://www.ncbi.nlm.nih.gov/pubmed/35116697
http://dx.doi.org/10.21037/tcr-21-561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797719/
https://www.ncbi.nlm.nih.gov/pubmed/35116697
http://dx.doi.org/10.21037/tcr-21-561

Ejemplares similares